Ripple Software Achieves 96% Clinical Trial Retention Share Article Ripple Science Logo ANN ARBOR, Mich. (PRWEB) May 10, 2021 A white paper recently published by Ripple Science revealed that its flagship product, Ripple, empowered its customers to achieve >96% retention across all trials and 99% retention in 78.2% of completed trials, far outpacing industry averages. Ripple Science is the leading provider of clinical trial software used by sites, CROs, and study sponsors to assist and automate the patient engagement workflow en...